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Background
Hypertrophic Cardiomyopathy (HCM) is characterized by 
excessive thickening of the heart muscle and myocardial disarray. 
Approximately 25% of the 1 in 500 individuals diagnosed with HCM 
have obstruction. Septal myectomy 
is considered the “gold standard” for 
treatment of HCM, with majority of 
patients receiving surgery at an average 
age of 50. In this retrospective study, 
the cohort having septal myectomy 
performed represent an older population 
averaging 70.6 years and are 
frequently admitted with other health 
complications resulting in concomitant 
procedures. 
Objective
Patients of an elderly, high-risk population were evaluated to 
determine if conducting a septal myectomy is an effective method 
for health and relief of symptoms.
Methods
Patient data was retrospectively reviewed for 34 patients receiving 
a septal myectomy within the Lehigh Valley Health Network from 
2006-2013. A cohort of 20 patients ranging from 60-84 years of 
age was selected. Data was obtained using the Lehigh Valley Health 
Network’s database and further analyzed in regards to effectiveness 
of septal myectomy in elderly and high-risk populations.
Result Figures
Table 1. Characteristics of Patients Undergoing 
Septal Myectomy
Characteristic No. (% of n or mean + SD)
Demography
Men 6 (30)
Age (years) 70.6 ± 6.0
Height (cm) 162.8 ± 11.1
Weight (kg) 86.7 ± 18.6
BMI 33 ± 8.1






Coronary Artery Disease 6 (30)




160% of patients had multiple symptoms, 245% of patients did not 
report contributory family history.
Table 2. Operative Procedures in 20 Elderly 
Myectomy Patients
Operation1 No. (%)




Left MAZE 3 (15)
Resection of Papillary Muscle 3 (15)
Redo Sternotomy 2 (10)
Patch VSD 1 (5)
Left Atrium Extraction 1 (5)
AV Repair 1 (5)
Plication of MVL 1 (5)
Repair Coronary Sinus 1 (5)
Ovale Closure 1 (5)
Repair Aortic Rupture 1 (5)
175% of patients had concomitant procedures
AVR=aortic valve replacement, CABG=coronary artery 
bypass graft, MV=mitral valve, VSD=ventricular septal defect, 
AVRepair=aortic valve repair, MVR=mitral valve replacement, 
MVL=mitral valve leaflet.
Table 3. Preoperative and Postoperative Data in 20 
Elderly Patients 
Finding No. (% of n, mean + SD) or median with IQR)
Preoperative
Septal Wall Thickness (cm) 2.29 ± .45
Peak LVOT Gradient (mmHg) 68; 57.5-89
Postoperative 
Peak LVOT Gradient (mmHg) 9; 6-19.5
Mass of Muscle Removed (g)  4.97 ± 1.99
Length of Stay (days) 5; 5-9.25
Permanent Pacemaker 7 (35)
Readmitted 3 (15)
Average patient functionality scores increased from 3/10 to 8/10 
postoperatively.
Results
All 20 patients were evaluated pre and post 
surgery, with 0 mortalities. Pre-surgery 
interventricular thickness was 2.29 ± .45 cm. 
Average mass of muscle removed was 4.97 ± 
1.99 grams. LVOT gradient was reduced from 
a median of 68 mmHg to 9 mmHg immediately 
postmyectomy, with an average length of stay of 
5 days. Permanent pacemakers were required in 
35% of patients, and 15% were readmitted. 
Conclusion
High risk patients showed significant decreases 
in LVOT gradients and functionality following 
septal myectomy. For high-risk patients presenting 
obstructive HCM, septal myectomy is an effective 
method that should be used as the first treatment 
of choice. 
Methods
Patient data was retrospectively reviewed 
for 34 patients receiving a septal 
myectomy within the Lehigh Valley Health 
Network from 2006-2013. A cohort of 
20 patients ranging from 60-84 years 
of age was selected. Data was obtained 
using the Lehigh Valley Health Network’s 
database and further analyzed in regards 
to effectiveness of septal myectomy in 
elderly and high-risk populations.
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